APR Swiss Pharmaceutical Healthcare Company
APR (Applied Pharma Research) is a Swiss independent pharmaceutical healthcare company, based in Balerna (Ticino area), next to Chiasso, Lugano and Milano. APR identifies, develops and licenses science driven, value added and patented healthcare products designed to address patient or consumer needs in niche or rare therapeutical areas on a global basis.
The company has a dedicated and experienced Pharmaceutical Research and Development Team focused on innovation in healthcare and a strong formulation and development knowhow, coupled with an extensive regulatory experience in US and EU.
APR has a balanced pipeline of revenue generating branded products marketed in all major markets, combined with a compelling pipeline of innovative products at different stages of development, which span several therapeutical areas: cancer supportive care, pain management, migraine, wound care, inherited metabolic diseases, ocular diseases, tissue transplantation, baby healthcare, proctology.
Main marketed products are either Rx, Medical Device or OTC as follows:
- Prescription Healthcare products: a patented formulation of Diclofenac for the treatment of migraine and acute pain, Nexodyn® AOS, an active cleanser for an optimized wound management and care, Setofilm®, Ondansetron Oral Dispersible Film (ODF) for cancer supportive care, in particular for the treatment of CINV, RINV and PONV, Exelya®, an effective, convenient and patient-friendly treatment option for acne.
- Consumer Healthcare products: Halykoo®, a complete range of high quality, science-driven healthcare solutions specific for baby needs, a set of Diclofenac formulations for acute pain treatment.
The development pipeline of the company is mainly focused on the following therapeutic areas: inherited metabolic disorders (Phenylketonuria), ocular diseases, rare dermatological diseases.
APR SA provides a wide range of services for the pharmaceutical and pharmacological industry on a contract basis: Research and Development services with complete supervision, management and execution of the entire project, development of oral and topical formulation and drug delivery technologies (pharma, nutraceuticals, dermocosmetics, Medical Devices).
APR Applied Pharma Research SA has entered into licensing and healthcare partnership agreements with pharmaceutical companies in over 70 countries with international sales on a worldwide basis.